Regulators Probing Whether Health Net Is Stiffing Drug Treatment Providers
Insurance officials in California have received widespread complaints that the insurer has not paid rehab centers for months, as the company sifts claims for fraud.
The independent source for health policy research, polling, and news.
1,261 - 1,280 of 1,305 Results
Insurance officials in California have received widespread complaints that the insurer has not paid rehab centers for months, as the company sifts claims for fraud.
With the nation’s opioid crisis worsening, officials want you to dispose of unwanted or expired prescription drugs. But finding a convenient take-back site requires time and patience.
A refrigerator-sized machine could someday make lifesaving drugs on site when outbreaks occur or where medicine is in short supply, like on the battlefield.
The FDA could soon approve an implantable form of a drug used to treat opioid addiction. While the approach helped patients avoid relapse in tests, its price may be prohibitive for some, doctors say.
A proposal to change the way Medicare pays for some drugs has set off intense reaction and lobbying — all tied to a common theme: How far should the government go in setting prices for prescription drugs?
UnitedHealth’s OptumRx is the lowest bidder and wins a key endorsement ahead of final vote by California’s public retirement system.
The U.S. faces a variety of serious concerns beyond just the future of the federal health law.
In June, California will become the fifth state to allow terminally ill patients to end their lives with prescriptions from their doctors, but getting those prescriptions will require serious effort.
The problems persist even after Congress in 2012 gave the FDA enhanced powers to respond when drug levels are low.
New research sheds light on the growing costs to the health care system associated with painkiller and heroin abuse.
Bad coordination and communication can put patients at risk as they're discharged from a hospital.
CVS rebuilt a store destroyed by protesters after Freddie Gray’s death last year, but a shortage of quality pharmacies means low-income residents still have unmet needs.
The analysis by Avalere examines changes in how silver plans on the insurance marketplaces handle coverage for high-cost specialty drugs.
How high-cost drugs are impacting California.
Every state except Missouri has a database that doctors can check to see if a person filling a prescription for an opioid is trying to get it from other pharmacies, too.
A survey conducted by the Leapfrog Group finds that though many hospitals have computer-based medication systems in place to protect against errors, many still fall short in highlighting possible problems.
A study published in Health Affairs examines how physician-patient interactions often present missed opportunities to control patients’ health care spending.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.
More Medicare Part D drug plans are requiring coinsurance rather than copayments for more types of medications, making beneficiaries’ costs less predictable.
© 2026 KFF